The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension (TRICOLOR)
Multinational Observational Uncontrolled Open Programme The Use of TRIple Fixed-dose COmbination in the Treatment of arteriaL Hypertension: Opportunity for Effective BP Control With cOmbined Antihypertensive Therapy
Sponsor: Servier Russia
A observational or N/A phase clinical study on Arterial Hypertension, this trial is completed. The trial is conducted by Servier Russia and has accumulated 10 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2021 — Jul 2024 [monthly]
Completed
-
Apr 2021 — Sep 2021 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 5 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Nov 2019 — Jan 2021 [monthly]
Recruiting
-
Apr 2019 — Nov 2019 [monthly]
Recruiting
-
Feb 2019 — Apr 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Feb 2019 [monthly]
Not Yet Recruiting
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Servier Russia
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Al'met'yevsk, Russia , Barnaul, Russia , Belgorod, Russia , Bryansk, Russia , Chelyabinsk, Russia , Cherepovets, Russia , Irkutsk, Russia , Ivanovo, Russia , Izhevsk, Russia , Kazan', Russia and 40 more locations